Insurance Stopped Covering Your GLP-1: A Calm, Next-Steps Guide
Your insurance stopped covering Ozempic or Wegovy? Take a breath. Here are calm, practical next steps: talk to your prescriber, appeal, and check savings programs.
You opened a letter, or got a message at the pharmacy counter, and learned that your insurance is no longer covering your GLP-1. If your stomach dropped, that is a completely understandable reaction. This is a stressful moment, and it can feel like the floor just moved. The good news: a coverage change is a problem with several practical paths forward, and you do not have to solve all of them today. Let's walk through the calm, orderly next steps, one at a time.
This is educational, not medical advice. Talk to your clinician before starting, stopping, or changing any medication.
First: do not stop on your own
A coverage lapse is not the same thing as a medical instruction to stop. It is easy to assume that no coverage means no medication, but the decision about whether, when, and how your treatment continues belongs to you and your prescriber, not to a formulary change. Stopping abruptly and without a plan is exactly the scenario research links to the return of appetite signals and gradual regain, because GLP-1 medications work while they are in your system and their effect fades as the drug clears. Before you change anything, get your clinician on the phone. Regain, if it happens, is physiology (your body's biology reasserting itself), never a personal failing.
Any change to your dose, schedule, or whether you continue at all is a clinician decision. Do not adjust or stop your medication on your own because of a coverage change. Call your prescriber first.
Talk to your prescriber first
Your prescriber's office deals with coverage denials constantly, and they have tools you do not. Call them, explain that coverage stopped, and ask them to help you map the options. Come to that conversation with a short list so nothing gets forgotten:
- Is there a prior authorization we can submit, or resubmit, with more clinical documentation?
- If coverage was denied, can we file a formal appeal, and what evidence strengthens it?
- Is there a covered alternative on my plan's formulary that would be appropriate for me?
- If we need to bridge a gap, what does a safe, clinician-guided plan look like? Some prescribers discuss options like a slower tapering approach rather than an abrupt stop.
- What should I watch for over the next few weeks so we can adjust early?
Ask about appeals and prior authorization
Coverage decisions are frequently reversible. A prior authorization is your plan's request for clinical justification, and a well-documented one, especially with your prescriber's support, can restore coverage. If a request was denied, most plans have a formal appeals process with defined deadlines, so it helps to act promptly. Your prescriber's office and your insurer's member services line can both tell you what the specific process and timeline look like for your plan. This step costs you time, not money, and it is often the highest-leverage thing you can do.
Check manufacturer savings programs
While the appeal is in motion, look at the manufacturers' own programs. Novo Nordisk runs NovoCare for medications like Ozempic and Wegovy, and Eli Lilly runs LillyDirect for Zepbound and Mounjaro. These can include savings cards for eligible people with commercial insurance and self-pay pricing for those without coverage. Eligibility and pricing change over time and depend on your situation, so confirm the current details directly with the program. To see how the numbers actually shake out for your dose and scenario, run them through our GLP-1 cost calculator before you make any decisions.
| Path | What it is | Who to talk to |
|---|---|---|
| Appeal / prior authorization | Ask your plan to reconsider or authorize coverage with clinical documentation | Prescriber's office + insurer member services |
| Covered alternative | A different formulary medication that may be appropriate for you | Your prescriber |
| Manufacturer program | NovoCare (Novo Nordisk) or LillyDirect (Lilly) savings and self-pay options | The program directly, plus your prescriber |
| Maintenance plan | Build the daily habits that protect your progress in parallel | You, with your care team |
Steer clear of compounded and gray-market sources
When cost pressure hits, online sellers offering cheap "compounded" or unbranded semaglutide and tirzepatide can look tempting. Be careful here. The FDA has issued warning letters and repeatedly flagged safety concerns around unapproved and improperly sourced GLP-1 products, including dosing errors and questionable ingredients. A coverage gap is stressful, but it is not worth taking on the risks of an unregulated supply. Keep any decisions inside the system of your prescriber and licensed pharmacies, and lean on the legitimate savings programs above instead.
Build your maintenance plan in parallel
Whatever happens with coverage, the habits that protect your progress are yours to keep, and this is a good moment to strengthen them. While you and your prescriber sort out the medication question, invest in the pillars that carry weight maintenance: a solid protein target, regular strength training to protect lean mass, and the broader routines in our maintenance guide. If you want more on managing the money side specifically, our breakdown of Ozempic cost without insurance goes deeper. Building these in parallel means that no matter how the coverage question resolves, you are not standing still.
The bottom line
Losing GLP-1 coverage is jarring, but it is a solvable logistics problem, not an emergency, and definitely not a reason to stop your medication on your own. Call your prescriber first, ask about appeals and prior authorization, explore NovoCare or LillyDirect, avoid compounded and gray-market sources, and keep building your maintenance habits alongside all of it. Take the next steps in order, give yourself some grace, and let your care team help you carry this.
Frequently asked questions
My insurance stopped covering Ozempic. Should I just stop taking it?
Not on your own. A coverage change is not a medical instruction to stop. Call your prescriber before adjusting anything, because whether and how you continue is a clinical decision, and stopping abruptly without a plan is linked to the return of appetite and gradual regain.
Can a GLP-1 coverage denial be reversed?
Often, yes. Many denials can be addressed through a prior authorization or a formal appeal, especially when your prescriber submits strong clinical documentation. Plans have defined appeal processes and deadlines, so it helps to start promptly. Ask your prescriber's office and your insurer's member services line about the specific steps.
What are NovoCare and LillyDirect?
They are the manufacturers' own programs. NovoCare is Novo Nordisk's program for medications like Ozempic and Wegovy, and LillyDirect is Eli Lilly's for Zepbound and Mounjaro. They can include savings cards for eligible people with commercial insurance and self-pay pricing options. Eligibility and pricing change, so confirm current details directly.
Are cheap compounded GLP-1s a safe way to save money?
They carry real risks. The FDA has issued warning letters and flagged safety concerns around unapproved and improperly sourced GLP-1 products, including dosing errors and questionable ingredients. A coverage gap is stressful, but the safer route is legitimate manufacturer programs and licensed pharmacies, coordinated through your prescriber.
What should I do while I sort out coverage?
Build your maintenance plan in parallel. Focus on the pillars that protect your progress: a solid protein target, regular strength training, and consistent daily routines. These habits are yours to keep regardless of how the coverage question resolves, so strengthening them now means you are not losing ground.
How do I estimate what my GLP-1 will cost now?
Run your dose and scenario through the GLP-1 cost calculator to compare self-pay pricing, savings-program pricing, and alternatives before you decide anything. Seeing the real numbers side by side makes the conversation with your prescriber and insurer far more concrete.
Sources & further reading
Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.
- [1]Wegovy (semaglutide) Cost, Coverage, and Savings ResourcesNovoCare
- [2]FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1sFDA
- [3]FDA to Telehealth Companies: What to Know When Promoting Compounded DrugsFDA
- [4]Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight LossNIH/PMC
What changed
- Initial publication.